Paxman

The company’s vision is to make scalp cooling technology available for all cancer patients worldwide. Scalp cooling is a well-accepted treatment throughout the world and Paxman are at the very heart of this with their market-leading scalp cooling system used to minimise hair loss caused by certain chemotherapy drugs.

Based in Huddersfield, the family-run business was founded by Glenn Paxman following his wife Sue Paxman’s hair loss in connection with chemotherapy treatment.

Glenn realised that there were shortcomings in the existing methods for scalp cooling and developed a liquid-based system together with his brother. Their understanding of how important it is for cancer patients to keep their hair, and thereby a certain amount of control over their daily lives, is reflected in all of Paxman’s business operations.  

The company’s vision is to make scalp cooling technology available for all cancer patients worldwide. Scalp cooling is a well-accepted treatment throughout the world and Paxman are at the very heart of this with their market-leading scalp cooling system used to minimise hair loss caused by certain chemotherapy drugs.  

The Paxman Scalp Cooling System provides a clinically proven alternative to hair loss during chemotherapy and a cost-effective system widely embraced by doctors, nurses and patients across the world. The pioneering technology aims to empower patients with a sense of control.  

Today Paxman’s clinically proven cold cap system has helped over 100,000 cancer patients worldwide to retain their hair during chemotherapy. Presently, the system is used at many cancer centres and hospitals in Europe, North, Central and South America, Asia and Oceania, and more installs are added continuously.  

The company is also involved in a collaborative research project with the National University, Singapore to develop a cooling product to prevent chemotherapy-induced peripheral neuropathy (CIPN) - nerve damage in hands and feet.  

With over 4,000 delivered systems and active in over 60 markets, Paxman has established itself as the leading player in its field. 

Find out more about the West Yorkshire Life Sciences Investment Zone

The West Yorkshire Life Sciences Investment Zone will bolster our already thriving health and digital ecosystem. Contact us to find out more and how you can get involved.